Showing results (1351-1360 of 2,938) with videos related to
Sort By:
Pageof 294
Cancer Investigation|December 18, 2009
Sorafenib therapy for metastatic renal carcinoma in patients with low cardiac ejection fraction: report of two cases and literature reviewPratima Kamada, Arkadiusz Z DudekCancer Investigation|December 18, 2009
IGF-1 partially restores chemotherapy-induced reductions in neural cell proliferation in adult C57BL/6 miceMichelle C Janelsins, Joseph A Roscoe, Michel J Berg, et al.Cancer Investigation|February 13, 2015
Could concomitant radio-chemotherapy improve the outcomes of early-stage node negative anal canal cancer patients? A retrospective analysis of 122 patientsBerardino De Bari, Laëtitia Lestrade, Pascal Pommier, et al.Cancer Investigation|February 10, 2015
RUNX3 Promoter Methylation Is Associated with Hepatocellular Carcinoma Risk: A Meta-AnalysisXueyan Zhang, Hairong He, Xu Zhang, et al.Cancer Investigation|February 4, 2015
ERCC1 SNPs as Potential Predictive Biomarkers in Non-Small Cell Lung Cancer Patients Treated With Platinum-Based ChemotherapyAristea Kalikaki, Alexandra Voutsina, Anastasios Koutsopoulos, et al.Cancer Investigation|October 2, 2012
Predictive biomarkers in breast cancer: their value in neoadjuvant chemotherapyL Fuksa, S Micuda, J Grim, et al.Cancer Investigation|October 2, 2012
Immune protection function of multipotent mesenchymal stromal cells: role of transforming growth factor-β1Zhi-Gang Zhao, Zeng Cao, Wen Xu, et al.Cancer Investigation|January 1, 1986
Comparison of metoclopramide and metoclopramide plus dexamethasone for complete protection from cisplatinum-induced emesisS M Grunberg, W L Akerley, M D Krailo, et al.Cancer Investigation|January 1, 1989
Increased susceptibility to inoculated Lewis lung carcinoma (3LL) but unaltered tumor growth in mice treated with monoclonal antibody to L3T4 on mouse T-helper cellsW B Ershler, R G Klopp, A L Moore, et al.Cancer Investigation|January 24, 2015
Pazopanib and liposomal doxorubicin in the treatment of patients with relapsed/refractory epithelial ovarian cancer: a phase Ib study of the Sarah Cannon Research InstituteJohn D Hainsworth, Irfan D Firdaus, Chris B Earwood, et al.Pageof 294